Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension

Introduction Despite new treatment options targeted at its three main pathogenic pathways, prognosis of idiopathic pulmonary arterial hypertension has remained dismal, with 3-year survival rates around 70 %. Antiproliferative agents have emerged as a new therapeutic concept. However, they may exert...

Descripción completa

Detalles Bibliográficos
Autores principales: Speich, Rudolf, Treder, Ursula, Domenighetti, Guido, Huber, Lars C., Ulrich, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984669/
https://www.ncbi.nlm.nih.gov/pubmed/24287663
http://dx.doi.org/10.1007/s11096-013-9881-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984669/
https://www.ncbi.nlm.nih.gov/pubmed/24287663
http://dx.doi.org/10.1007/s11096-013-9881-x

Ejemplares similares